145 related articles for article (PubMed ID: 10871746)
21. Live cell vaccines expressing B7.1, monocyte chemoattractant protein 1 and granulocyte-macrophage colony stimulation factor derived from mouse HPV16-transformed cells.
Lakatosová-Andelová M; Jinoch P; Dusková M; Marinov I; Vonka V
Int J Oncol; 2008 Jan; 32(1):265-71. PubMed ID: 18097567
[TBL] [Abstract][Full Text] [Related]
22. Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer.
Williams CC; Trinh H; Tran TV; Dan Q; Sanchez R; Delgado C; Chen Y; Sippel B; Jeffes EW; Wepsic HT; Jadus MR
Mol Ther; 2001 Feb; 3(2):216-24. PubMed ID: 11237678
[TBL] [Abstract][Full Text] [Related]
23. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
[TBL] [Abstract][Full Text] [Related]
24. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.
Yang W; Barth RF; Wu G; Kawabata S; Sferra TJ; Bandyopadhyaya AK; Tjarks W; Ferketich AK; Moeschberger ML; Binns PJ; Riley KJ; Coderre JA; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
Clin Cancer Res; 2006 Jun; 12(12):3792-802. PubMed ID: 16778107
[TBL] [Abstract][Full Text] [Related]
25. Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
Szpechcinski A; Trzos R; Jarocki P; Trojan LA; Oficjalska K; Junkiert A; Wei MX; Mazurek M; Czapiewska JL; Niklinski J; Kopiński P; Chyczewski L; Kasacka I; Trojan J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():98-104. PubMed ID: 15638388
[TBL] [Abstract][Full Text] [Related]
26. Co-modification of IL-2-TNF alpha fusion gene and B7.1 gene to murine breast tumor cells leads to improved tumor rejection and vaccine effect.
Liu X; Zhang L; Zhang M; Ma Y; Xu X; Cai Y
Chin Med J (Engl); 2000 Feb; 113(2):167-71. PubMed ID: 11775545
[TBL] [Abstract][Full Text] [Related]
27. Tumor cells cotransduced with B7.1 and gamma-IFN induce effective rejection of established parental tumor.
Yang S; Vervaert CE; Seigler HF; Darrow TL
Gene Ther; 1999 Feb; 6(2):253-62. PubMed ID: 10435110
[TBL] [Abstract][Full Text] [Related]
28. Suppression of peritoneal metastasis in human gastric carcinoma by enhanced immunogenicity of B7-1 transfection.
Sakate Y; Yashiro M; Tanaka H; Kosaka K; Ohira M; Hirakawa K
Oncol Rep; 2004 Jul; 12(1):53-7. PubMed ID: 15201958
[TBL] [Abstract][Full Text] [Related]
29. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
[TBL] [Abstract][Full Text] [Related]
30. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
[TBL] [Abstract][Full Text] [Related]
31. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
[TBL] [Abstract][Full Text] [Related]
32. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated in vivo B7-1 gene transfer induces anti-tumor immunity against pre-established primary tumor and pulmonary metastasis of rat osteosarcoma.
Tsuji H; Kawaguchi S; Wada T; Nagoya S; Inobe M; Yamashita T; Ishii S; Uede T
Cancer Gene Ther; 2002 Sep; 9(9):747-55. PubMed ID: 12189524
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
Larchian WA; Horiguchi Y; Nair SK; Fair WR; Heston WD; Gilboa E
Clin Cancer Res; 2000 Jul; 6(7):2913-20. PubMed ID: 10914741
[TBL] [Abstract][Full Text] [Related]
35. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity.
Si SY; Hu PZ; Huang YY; Ye J; Huang Y; Li ZS; Ge W; Li X; Qu P; Zhang XM; Sui YF
Biochem Biophys Res Commun; 2006 Aug; 347(1):208-14. PubMed ID: 16814254
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer.
Raez LE; Cassileth PA; Schlesselman JJ; Sridhar K; Padmanabhan S; Fisher EZ; Baldie PA; Podack ER
J Clin Oncol; 2004 Jul; 22(14):2800-7. PubMed ID: 15254047
[TBL] [Abstract][Full Text] [Related]
37. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC
Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624
[TBL] [Abstract][Full Text] [Related]
38. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis.
Wintterle S; Schreiner B; Mitsdoerffer M; Schneider D; Chen L; Meyermann R; Weller M; Wiendl H
Cancer Res; 2003 Nov; 63(21):7462-7. PubMed ID: 14612546
[TBL] [Abstract][Full Text] [Related]
39. Response of MHC class-1 antigen on rat glioma cells to cytokines.
Oshiro S; Fukushima T; Tomonaga M; Black KL
Anticancer Res; 2000; 20(1C):605-10. PubMed ID: 10769703
[TBL] [Abstract][Full Text] [Related]
40. Intramuscular gene transfer of soluble B7.1/IgG(1) fusion cDNA induces potent antitumor immunity as an adjuvant for DNA vaccination.
Zhou ZF; Peretz Y; Chang Y; Miao DS; Li X; Prud'homme GJ
Cancer Gene Ther; 2003 Jun; 10(6):491-9. PubMed ID: 12768195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
